[1]LLEO A, OERTELT-PRIGIONE S, BIANCHI I, et al.Y chromosome loss in male patients with primary biliary cirrhosis[J].J Autoimmun, 2013, 41:87-91.[2]SELMI C, MAYO MJ, BACH N, et al.Primary biliary cirrhosis in monozygotic and dizygotic twins:genetics, epigenetics, and environment[J].Gastroenterology, 2004, 127 (2) :485-492.[3]Hirschfield GM, Invernizzi P.Progress in the genetics of primary biliary cirrhosis[J].Semin Liver Dis, 2011, 31 (2) :147-156.[4]LI Q, WANG B, PAN F, et al.Association between cytotoxic T-lymphocyte antigen 4 gene polymorphisms and primary biliary cirrhosis in Chinese population:data from a multicenter study[J].J Gastroenterol Hepatol, 2013, 28 (8) :1397-1402.[5]MANTAKA A, GOULIELMOS GN, KOULENTAKI M, et al.Polymorphisms of genes related to endothelial cells are associated with primary biliary cirrhosis patients of cretan origin[J].Hum Immunol, 2012, 73 (8) :829-835.[6]INAMINE T, HIGA S, NOGUCHI F, et al.Association of genes involved in bile acid synthesis with the progression of primary biliary cirrhosis in Japanese patients[J].J Gastroenterol, 2013 Jan 11.[Epub ahead of print][7]KIMURA Y, SELMI C, LEUNG PS, et al.Genetic polymorphisms influencing xenobiotic metabolism and transport in patients with primary biliary cirrhosis[J].Hepatology, 2005, 41 (1) :55-63.[8]LAMMERTC, NGUYEN DL, JURAN BD, et al.Queationaire based assessment of risk factors for primary biliary cirrhosis[J].Dig Liver Dis, 2013, 45 (7) :589-594.[9]SHAPIRA Y, AGMON-LEVIN N, RENAUDINEAU Y, et al.Serum markers of infections in patients with primary biliary cirrhosis:evidence of infection burden[J].Exp Mol Pathol, 2012, 93 (3) :386-390.[10]MOHAMMED JP, FUSAKIO ME, RAINBOW DB, et al.Identification of Cd101 as a susceptibility gene for Novosphingobium a romaticivorans-induced liver autoimmunity[J].J Immunol, 2011, 187 (1) :337-349.[11]MASON AL.The evidence supports a viral aetiology for pimary biliary cirrhosis[J].J Hepatol, 2011, 54 (6) :1312-1314.[12]XU L, SHEN Z, GUO L, et al.Does a betaretrovirus infection trigger primary biliary cirrhosis?[J].Proc Natl Acad Sci U S A, 2003, 100 (14) :8454-8459.[13]NAIYANETR P, BUTLER JD, MENGL, et al.Electrophile-modified lipoic derivatives of PDC-E2 elicits anti-mitochondrial antibody reactivity[J].J Autoimmun, 2011, 37 (3) :209-216.[14]SELMI C, BOWLUS CL, GERSHWIN ME, et al.Primary biliary cirrhosis[J].Lancet, 2011, 377 (9777) :1600-1609.[15]BOGDANOS DP, INVERNIZZI P, MACKAY IR, et al.Autoimmune liver serology:current diagnostic and clinical challenges[J].World J Gastroenterol, 2008, 14 (21) :3374-3387.[16]SASAKI M, MIYAKOSHI M, SATO Y, et al.Increased expression of mitochondrial proteins associated with autophagy in biliary epithelial lesions in primary biliary cirrhosis[J].Liver Int, 2013, 33 (2) :312-320.[17]LAN RY, SALUNGA TL, TSUNEYAMA K, et al.Hepatic IL-17responses in human and murine primary biliary cirrhosis[J].J Autoimmun, 2009, 32 (1) :43-51.[18]LAN RY, CHENG C, LIAN ZX, et al.Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis[J].Hepatology, 2006, 43 (4) :729-737.[19]BERNUZZI F, FENOGLIO D, BATTAGLIA F, et al.Phenotypical and functional alterations of CD8 regulatory T cells in primary biliary cirrhosis[J].J Autoimmun, 2010, 35 (3) :176-180.[20]LLEO A, BOWLUS CL, YANG GX, et al.Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis[J].Hepatology, 2010, 52 (3) :987-998.[21]YOU ZR, WANG QX, BIAN ZL, et al.The immunopathology of liver granulomas in primary biliary cirrhosis[J].J Autoimmun, 2012, 39 (3) :216-221.[22]GRAHAM RP, SMYRK TC, ZHANG L, et al.Evaluation of langerhans cell infiltrate by CD1a immunostain in liver biopsy for the diagnosis of primary biliarycirrhosis[J].Am J Surg Pathol, 2012, 36 (5) :732-736.[23]KAKUDA Y, HARADA K, SAWADA-KITAMURA S, et al.Evaluation of a new histologic staging and grading system for primary biliary cirrhosis in comparison with classical systems[J].Hum Patho, 2013, 44 (6) :1107-1117.[24]DREBBER U, MUELLER JJ, KLEIN E, et al.Liver biopsy in primary biliary cirrhosis:Clinicopathological data and stage[J].Pathol Int, 2009, 59 (8) :546-554.[25]ALEMPIJEVIC T, KRSTIC M, JESIC R, et al.Biochemical markers for non-invasive assessment of disease stage in patients with primary biliary cirrhosis[J].World J Gastroenterol, 2009, 15 (5) :591-594.[26]MA JL, WANG R, ZHANG FK, et al.A noninvasive diagnostic model of liver fibrosis using serum markers in primary biliary cirrhosis[J].Chin J Int Med, 2012, 51 (8) :618-622. (in Chinese) 马佳丽, 王蕊, 张福奎, 等.原发性胆汁性肝硬化无创性肝纤维化诊断模型的建立[J].中华内科杂志, 2012, 51 (8) :618-622.[27]INVERNIZZI P, CROSIGNANI A, BATTEZZATI PM, et al.Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and-negative primary biliary cirrhosis[J].Hepatology, 1997, 25 (5) :1090-1095.[28]DANIELS JA, TORBENSON M, ANDERS RA, et al.Immunostaining of plasma cells in primary biliary cirrhosis[J].Am J Clin Pathol, 2009, 131 (2) :243-249.[29]TU CT, HAN B, ZHANG SC.Clinical and histological characteristics of the primary biliary cirrhosis and autoimmune hepatitis overlap sydrome:a retrospective study[J].Chin J Gasteroenterol Hepatol, 2010, 19 (2) :166-169. (in Chinese) 涂传涛, 韩冰, 张顺财.PBC-AIH重叠综合征临床与病理特征:一项回顾性研究[J].胃肠病学和肝脏病学杂志, 2010, 19 (2) :166-169.[30]BARAKAUSKIENE·A, SPEICˇIEN E·D, LIAKINA V, et al.Expression of cytokeratin 7 as a histological marker of cholestasis and stages of primary biliary cirrhosis[J].Medicina, 2011, 47 (1) :31-38.[31]KUMAGI T, GUINDI M, FISCHER SE, et al.Baseline ductopenia and treatment response predict long-term histological progression in primary biliarycirrhosis[J].AM J Gastroenterol, 2010, 105 (10) :2186-2194.[32]DUAN WJ, JIA JD.Review of clinical improvements in autoimmune liver diseases2010[J].J Clin Hepatol, 2011, 27 (6) :567-569. (in Chinese) 段维佳, 贾继东.2010年自身免疫性肝病临床进展回顾[J].临床肝胆病杂志, 2011, 27 (6) :567-569.
|